MADRIGAL PHARMACEUTICALS, INC.

Pharmaceutical Preparations·WEST CONSHOHOCKEN, PA·FY end 12/31·CIK 1157601

CEO Pay Ratio

47:1

Bill Sibold

CEO Total Comp

$19.2M

Bill Sibold

Median Employee

$403,403

Revenue

$958.4M

FY 2025

Net Income

-$288.3M

FY 2025

Free Cash Flow

-$190.0M

FY 2025

Net Margin

-30.1%

Insider Net (180d)

-$61.6M

0 buys / 142 sales

CEO Pay Accountability

CEO comp as % of net income

-6.66%

For every $1,000 of profit, $-66.62 flows to the CEO.

CEO comp as % of buybacks

—

No buyback data for the most recent fiscal year.

5-year history · USD

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	Trend
Revenue	$958.4M	$180.1M	—	—	—
Gross Profit	—	—	—	—	—	—
Operating Income	-$300.1M	-$497.9M	-$117.2M	-$85.3M	-$64.6M
Net Income	-$288.3M	-$465.9M	-$112.2M	-$85.9M	-$64.5M
Operating CF	-$189.6M	-$455.6M	-$324.2M	-$224.9M	-$183.9M
Capex	$467.0K	$1.5M	$1.5M	$217.0K	$209.0K
Free Cash Flow	-$190.0M	-$457.0M	-$325.7M	-$225.1M	-$184.1M
Buybacks	—	—	—	—	—	—
Dividends	—	—	—	—	—	—

Gross Margin	—	—	—	—	—	—
Operating Margin	-31.3%	-276.4%	—	—	—
Net Margin	-30.1%	-258.6%	—	—	—
FCF Margin	-19.8%	-253.7%	—	—	—
R&D / Revenue	—	—	—	—	—	—
Effective Tax	—	—	—	—	—	—
Debt / Equity	1.13	0.31	0.57	0.60	—
Buybacks / FCF	—	—	—	—	—	—

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Bill SiboldPresident and Chief Executive Officer	$918.5K	$12.3M	$4.5M	$1.4M	$14.0K	$19.2M
David SoergelM.D. Executive Vice President and Chief Medical Officer	$418.2K	$5.9M	$2.2M	$659.1K	—	$9.2M
Rebecca TaubM.D. Senior Scientific and Medical Advisor and Former President, Research & Development and Chief Medical Officer	$617.5K	$4.1M	$1.5M	$604.5K	—	$6.9M
Mardi DierExecutive Vice President and Chief Financial Officer	$566.0K	$3.6M	$1.3M	$554.2K	$89.3K	$6.1M
Carole HuntsmanExecutive Vice President and Chief Commercial Officer	$540.3K	$3.2M	$1.2M	$529.0K	$9.8K	$5.4M
Shannon KelleyExecutive Vice President and Chief Legal Counsel	$535.2K	$3.0M	$1.1M	$523.9K	$14.0K	$5.2M